" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DNASTAR Software Releases Lasergene 10.1

Published: Monday, February 04, 2013
Last Updated: Monday, February 04, 2013
Bookmark and Share
New software supports automated bacterial genome closure and epitope prediction.

DNASTAR® has announced the release of Lasergene 10.1 as a Sanger and next-generation sequence assembly and analysis software upgrade with major enhancements to its desktop software suite for molecular biologists.

Lasergene 10.1 continues DNASTAR’s track record of releasing software that features significant enhancements semi-annually.

While there are many new features, functions, and enhanced workflows included in Lasergene 10.1, two improvements users will notice immediately are automated bacterial genome closure and epitope prediction.

The automated bacterial genome closure capability arose out of the vast experience DNASTAR has with software development, providing sequencing services, and working with bacterial samples.

As Tom Schwei, the Vice President and General Manager of DNASTAR, stated, “In Lasergene 10.1, we have automated a workflow that we’ve had in place for many years for closing novel bacterial genomes. In several examples using both Illumina and Ion Torrent next-generation sequencing data, our new automated workflow resolves 80% - 90% of structural variations otherwise identified when trying to assemble data using a closely related genome.”

Also in the next-generation sequencing area, the Lasergene 10.1 release continued to build on the company’s clinical research software platform, with added capability to include phenotypic data in clinical trial genomic data analysis and additional statistics relevant to data from any size clinical trial.

The proteomics component of Lasergene was also dramatically enhanced in Lasergene 10.1. Lasergene now includes epitope prediction based on a combination of bioinformatic methods applied to protein sequence data.

Protean 3D, which integrates protein sequence, structure, and bioinformatic data in one analytical toolset, also now includes alignment of multiple protein structures and presentation of molecular surfaces.

Finally, the SeqNinja application that was introduced in Lasergene 10 as a powerful tool for quickly manipulating and modifying large or complex sets of genomic data or editing sequence data and annotations across large data sets, was enhanced in Lasergene 10.1 by the addition of a graphical user interface and pre-set templates for common functions.

Schwei commented, “We remain committed to bringing exceptional functionality to the market through a broad range of significant software improvements twice each year. Our customers have come to rely on this schedule and their feedback is that this is the right frequency to keep up with the fast pace of developments in the field.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DNASTAR Appoints Pure Health Medical Supplies
Company appoints Purehealth as distributor of molecular biology software in the Middle East.
Thursday, September 24, 2015
DNASTAR Appoints Biotech Del Norte Mexico as Distributor
Biotech del Norte distributes Company’s DNA, RNA and protein sequence analysis software in Mexico.
Wednesday, August 05, 2015
DNASTAR Appoints Tom Lynch Vice President of Sales
Dr. Lynch played key roles in the successful launch of Aldevron’s recombinant protein business.
Wednesday, January 21, 2015
DNASTAR Awarded Antibody Engineering Software SBIR Grant
Company receives Phase II SBIR grant award from the National Institutes of Health.
Tuesday, September 16, 2014
DNASTAR Awarded Structural Biology Software SBIR Grant
Company receives Phase I SBIR grant award from the National Institutes of Health.
Wednesday, June 11, 2014
Wellcome Trust Sanger Institute Adopts DNASTAR Lasergene Software
Wellcome Trust Sanger Institute and DNASTAR have entered into a multi-year software license agreement.
Thursday, December 05, 2013
DMNB Adopts DNASTAR Lasergene Software
New Lasergene software site license agreement for genome sequence assembly and analysis.
Thursday, September 05, 2013
Dalhousie Medicine New Brunswick Adopts DNASTAR Lasergene Software
DMNB has entered into an agreement supporting an enterprise-wide site license of DNASTAR Lasergene software for genome sequence assembly and analysis.
Thursday, September 05, 2013
Eppley Institute Adopts DNASTAR Software
New site license of DNASTAR Lasergene software for use in sequence assembly and analysis.
Thursday, July 04, 2013
DNASTAR Awarded Fast-Track Phase I and Phase II SBIR Grant
Company receives grant award from NIH to support the development of software for clinical research.
Wednesday, September 26, 2012
DNASTAR Awarded Antibody Engineering SBIR Grant
NIH awarded grant to build antibody engineering software.
Tuesday, May 15, 2012
DNASTAR Partners with Ion Torrent
Ion Torrent offers DNASTAR’s sequence assembly and analysis software products to the customers through the Ion Torrent on-line web store in the collaboration.
Wednesday, February 16, 2011
DNASTAR Software Grant Supports Ion Torrent Awards
Firm will provide licenses of its next-gen sequencing suite of software tools to the two European winners of the extension of the grant program.
Monday, June 14, 2010
DNASTAR Joins BioIT Alliance
BioIT Alliance announces the expansion of the BioIT Alliance program to include DNASTAR.
Thursday, January 28, 2010
DNASTAR and the University of Iowa Sign Lasergene Site License Agreement
Researchers on the University of Iowa campus have gained unlimited access and use of the software for their sequence analysis projects.
Wednesday, January 06, 2010
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!